Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]        
Revenue, net $ 7,725 $ 5,753 $ 20,005 $ 16,062
Cost of revenue (excluding amortization of $995 and $813 for the three months and $2,621 and $2,439 for the nine months, respectively) 4,835 2,763 10,489 7,590
Gross profit 2,890 2,990 9,516 8,472
Operating expenses:        
Sales and marketing 2,757 2,048 8,127 6,135
Research and development 857 510 2,032 1,528
General and administrative 4,492 2,084 9,790 5,981
Acquisition related expense 838 2,534
Acquisition related amortization expense 995 813 2,621 2,439
Total operating expenses 9,939 5,455 25,104 16,083
Operating loss (7,049) (2,465) (15,588) (7,611)
Accretion expense (111) (248) (331) (248)
Other (expense) income, net (135) (288) (12) (143)
Loss from continuing operations before tax (7,295) (3,001) (15,931) (8,002)
Provision for income taxes 9 7 19 21
Loss from continuing operations (7,304) (3,008) (15,950) (8,023)
Income (loss) from discontinued operations, net of tax (58) (34) (51) (129)
Net loss (7,362) (3,042) (16,001) (8,152)
Net loss attributable to preferred shareholders (7,362) (16,001)
Less dividends on preferred stock (75) (75)
Net loss attributable to common shareholders $ (7,437) $ (16,076)  
Basic and diluted (loss) income per share of common stock:        
From continuing operations $ (0.19) $ (0.11) $ (0.43) $ (0.29)
From discontinued operations (0.00) (0.00) (0.00) (0.00)
Net loss per basic and diluted share of common stock $ (0.19) $ (0.11) $ (0.43) $ (0.29)
Weighted average number of common shares and common share equivalents outstanding:        
Basic 38,196 28,215 37,169 28,002
Diluted 38,196 28,215 37,169 28,002